Literature DB >> 27085823

Short term complications from transurethral resection of bladder tumor.

Justin R Gregg1, Benjamin McCormick, Li Wang, Paul Cohen, Daniel Sun, David F Penson, Joseph A Smith, Peter E Clark, Michael S Cookson, Daniel A Barocas, Matthew J Resnick, Kelvin A Moses, Sam S Chang.   

Abstract

INTRODUCTION: The diagnosis and subsequent management of bladder cancer often involves transurethral resection of bladder tumor (TURBT). Risks of TURBT include perioperative complications such as bleeding, pain and perforation. We aimed to determine TURBT complication rates and risk factors in a contemporary series.
MATERIALS AND METHODS: From 2002 to 2011, 505 patients underwent TURBT either for suspected bladder cancer or during follow up at a single institution. Baseline patient characteristics and complications within 2 weeks of surgery were extracted from the electronic medical record for all TURBTs. Patient and tumor characteristics were evaluated for associations with complication using univariate analysis. A multivariable logistic regression was fit to further examine associations between TURBT related characteristics and complication.
RESULTS: A total of 910 TURBTs were performed on 505 patients. Overall complication rate was 8.1%. The most common complications were pain or spasm (3.0%), retention (2.8%), and infection (2.1%), and 0.5% of TURBTs had perforation. Over 85% of complications were Clavien-Dindo grade I or II. Forty-three patients had a complication after their first TURBT, while 25 had complications after subsequent TURBTs. Prior complication and single tumor, but not other patient or tumor-related characteristics, were associated with complication. Only prior complication (p < 0.01) was associated with subsequent complication after TURBT on multivariable analysis.
CONCLUSIONS: Complication rate after TURBT is 8.1% and complications are generally not severe in nature. Prior short term complication is likely associated with subsequent complication. Further studies are needed to validate these results and determine patient groups most at risk for intraoperative and post TURBT complications.

Entities:  

Mesh:

Year:  2016        PMID: 27085823

Source DB:  PubMed          Journal:  Can J Urol        ISSN: 1195-9479            Impact factor:   1.344


  14 in total

1.  Comparison of three different antibiotic protocols in transurethral resection of bladder tumour and the possible infectious risk factors: A non-randomized, prospective study.

Authors:  Jorge Panach-Navarrete; Lorena Valls-González; Eduardo Sánchez-Cano; María Medina-González; Ana Castelló-Porcar; José María Martínez-Jabaloyas
Journal:  Can Urol Assoc J       Date:  2018-06-08       Impact factor: 1.862

2.  The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non-muscle-invasive bladder cancer.

Authors:  Florian R Schroeck; Kristine E Lynch; Zhongze Li; Todd A MacKenzie; David S Han; John D Seigne; Douglas J Robertson; Brenda Sirovich; Philip P Goodney
Journal:  Cancer       Date:  2019-05-23       Impact factor: 6.860

3.  Non-muscle invasive bladder cancer cystoscopic surveillance: from overuse to underuse and non-adherence impact.

Authors:  Leonardo O Reis
Journal:  Transl Androl Urol       Date:  2019-12

4.  En-bloc resection of bladder tumour as primary treatment for patients with non-muscle-invasive bladder cancer: routine implementation in a multi-centre setting.

Authors:  Jeremy Yuen-Chun Teoh; Nikhil Mayor; Kai-Man Li; Ka-Lun Lo; Chi-Fai Ng; Hugh Mostafid
Journal:  World J Urol       Date:  2021-03-28       Impact factor: 4.226

5.  Efficacy and safety of transurethral resection of bladder tumor for superficial bladder cancer.

Authors:  Wei Tang; Huiqing Niu; Yunbo Yang; Hui Li; Haichao Liu; Jiaxing Zhang; Peng Zhang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 6.  Nanotechnology in Bladder Cancer: Diagnosis and Treatment.

Authors:  Mahmood Barani; Seyedeh Maryam Hosseinikhah; Abbas Rahdar; Leila Farhoudi; Rabia Arshad; Magali Cucchiarini; Sadanand Pandey
Journal:  Cancers (Basel)       Date:  2021-05-05       Impact factor: 6.639

7.  The safety and efficacy of front-firing green-light laser endoscopic en bloc photoselective vapo-enucleation of non-muscle-invasive bladder cancer.

Authors:  Bo Cheng; Xiaofu Qiu; Huanhui Li; Guosheng Yang
Journal:  Ther Clin Risk Manag       Date:  2017-08-11       Impact factor: 2.423

8.  Bladder perforation during transurethral resection of bladder tumour is not a result of a deficient structure of the bladder wall.

Authors:  Sławomir Poletajew; Tomasz Ilczuk; Wojciech Krajewski; Grzegorz Niemczyk; Agata Cyran; Łukasz Białek; Piotr Radziszewski; Barbara Górnicka; Piotr Kryst
Journal:  World J Surg Oncol       Date:  2020-08-19       Impact factor: 2.754

9.  Establishing a prediction model of infection during the intravesical instillation of bladder cancer: a multicenter retrospective study.

Authors:  Song Chen; Yun Yang; Ziyi Luo; Haiqing Deng; Tiancheng Peng; Zhongqiang Guo
Journal:  J Cancer       Date:  2020-04-27       Impact factor: 4.207

10.  Prediction of the risk of surgical complications in patients undergoing monopolar transurethral resection of bladder tumour - a prospective multicentre observational study.

Authors:  Sławomir Poletajew; Wojciech Krajewski; Dominika Gajewska; Joanna Sondka-Migdalska; Michał Borowik; Paweł Buraczyński; Mateusz Dzięgała; Marcin Łykowski; Maciej Przudzik; Andrzej Tukiendorf; Rafał Woźniak; Krzysztof Bar; Zbigniew Jabłonowski; Marek Roslan; Marcin Słojewski; Romuald Zdrojowy; Piotr Radziszewski; Konrad Dziobek
Journal:  Arch Med Sci       Date:  2019-10-07       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.